Log in

Proteovant Therapeutics
Helai Mohammad

Helai Mohammad

VP, Biology at Proteovant Therapeutics

Helai has 15+ years of experience in oncology research with an emphasis on epigenetics. Previously Senior Scientific Director at GlaxoSmithKline.

Org chart

View in org chart

Manager

Drew Fromkin

CEO

Peers

Zhihua Sui

Chief Scientific Officer

Scott Priestley

VP, Discovery Chemistry

Winston Wu

VP, CMC

View in org chart

Timeline

VP, Biology
Current role

A panel showing how The Org can help with contacting the right person.

Related people